Source: International Congress 2015 – Immune mechanisms in the human lung
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Yoshinori Takahashi (Tsu shi, Japan), Yoshinori Takahashi, Kentaro Urata, Atsushi Tomaru, Kentaro Fujiwara, Masahiro Onishi, Takehiro Takagi, Hiroyasu Kobayashi, Corina D’Alessandro-Gabazza, Esteban Gabazza, Osamu Taguchi, Tetsu Kobayashi. The immunomodulatory activity of protein S protects against allergic airway inflammation. Eur Respir J 2015; 46: Suppl. 59, 4031

Member's Comments

No comment yet.

Related content which might interest you: PI3Kδ inhibition confer efficacy in experimental models of allergic airway inflammation Source: International Congress 2015 – Immune mechanisms in the human lung Year: 2015 Schistosome-induced pulmonary B cells inhibit allergic airway inflammation and display a reduced Th2-driving function Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions Year: 2015 Osteopontin binds and modulate the antibacterial action of eosinophil-recruiting chemokines during allergic inflammation Source: International Congress 2015 – Immune mechanisms in the human lung Year: 2015 GARP reduces inflammation in a humanized mouse model of allergic airway disease Source: International Congress 2015 – Advances in asthma and allergy in animal models Year: 2015 Exosomal microRNAs in the serum are potential real-time biomarkers for allergic inflammation in the airway of mice Source: International Congress 2014 – Mechanistic murine studies of asthma and lung inflammation Year: 2014 Adjuvant-free mouse model of allergic asthma Source: International Congress 2014 – Asthma: clinical problems Year: 2014 D-tryptophan influences allergic airway inflammation and Th2 immune responses Source: International Congress 2015 – Asthma mechanisms and management Year: 2015 Immunohistochemical study on changes of mast cell populations during allergic airway inflammation in mice using HDM model Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions Year: 2015 Vitamin C inhibits the diisocyanate-induced lung inflammatory response in mice Source: International Congress 2015 – Therapeutic approaches in inflammatory lung disease Year: 2015 Dose-dependent differential effects of thrombin in allergic bronchial asthma Source: Annual Congress 2013 –Murine models of lung immunology Year: 2013 Airway surface dehydration confers susceptibility to allergic airway inflammation in vivo Source: Annual Congress 2013 –Cell signalling and inflammation: what's new in 2013? Year: 2013 IL-13 in a mouse model of chemical-induced airway hyperresponsiveness Source: International Congress 2015 – Immune mechanisms in the human lung Year: 2015 Characteristics of IL-25 and allergen-induced airways fibrosis in a murine model of asthma Source: International Congress 2015 – The immunology of allergic airway disease Year: 2015 Immunomodulatory role of IL-37 in asthma pathogenesis Source: International Congress 2016 – Immune responses in the lung Year: 2016 Transient receptor potential channels in a mouse model of isocyanate-induced airway hyperresponsiveness Source: International Congress 2014 – Mechanistic murine studies of asthma and lung inflammation Year: 2014 HMGB1 expression and function in the allergic airway immune response Source: International Congress 2014 – Exploring molecular mechanisms of allergy and asthma in animal models Year: 2014 Systemic characterization of macrophage phenotypes in allergic airway inflammation Source: International Congress 2014 – Mechanistic murine studies of asthma and lung inflammation Year: 2014 Pim1 kinase affects allergic asthma in a HDM-driven mice model Source: International Congress 2014 – Mechanistic murine studies of asthma and lung inflammation Year: 2014 RIG-I receptors induced by dsRNA challenges in an HDM-mouse model of asthma exacerbation Source: International Congress 2014 – Exploring molecular mechanisms of allergy and asthma in animal models Year: 2014 Oral administration of saccharomyces cerevisiae inhibits the allergic airway response in mice Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases Year: 2013